Tantargy

Data

Official data in SubjectManager for the following academic year: 2024-2025

Course director

Almási Attila
associate professor,
Department of Paediatrics
attila.almasi@aok.pte.hu

Number of hours/semester

Lectures: 28 hours

Practices: 56 hours

Seminars: 0 hours

Total of: 84 hours

Subject data

Code of subject: OPG-GK1-T
6 Credit
Pharmacy
Pharmaceutical theoretical module and practical skills module
autumn

Prerequisites:

OPA-AN2-T finished , OPA-SV1-T finished , OPA-AM2-T finished

Course headcount limitations

min. 5 people – max. 50 people

Topic

Introduction to the quality control of substances used in pharmaceutical compounding. Pharmacopoeal analysis of selected inorganic substances. Introduction to the pharmacokinetics and pharmacodynamics of drug action. Molecular aspects and structure activity relationship of selected groups of active pharmaceutical ingredients with central nervous system activity.

Lectures

1.
Introduction. History and development of drug control. The European Pharmacopoeia. The pharmacopoeial nomenclature of substances.
- Almási Attila
2.
Introduction. History and development of drug control. The European Pharmacopoeia. The pharmacopoeial nomenclature of substances.
- Almási Attila
3.
Physical and physicochemical methods of the European Pharmacopoeia.
Identification and qualitative tests of the European Pharmacopoeia.
- Kulcsár Győző Kornél
4.
Physical and physicochemical methods of the European Pharmacopoeia.
Identification and qualitative tests of the European Pharmacopoeia.
- Kulcsár Győző Kornél
5.
Protein-specific test methods of the European Pharmacopoeia.
- Almási Attila
6.
Protein-specific test methods of the European Pharmacopoeia.
- Almási Attila
7.
The fate of xenobiotics in the body.
The receptor theory.
- Rozmer Zsuzsanna
8.
The fate of xenobiotics in the body.
The receptor theory.
- Rozmer Zsuzsanna
9.
Molecular basis of drug action. Physico-chemical parameters affecting drug-target interactions.
- Rozmer Zsuzsanna
10.
Molecular basis of drug action. Physico-chemical parameters affecting drug-target interactions.
- Rozmer Zsuzsanna
11.
Structural and physical chemical basis of drug action. Structure-activity relationships. The stereochemistry of the molecules.
- Kulcsár Győző Kornél
12.
Structural and physical chemical basis of drug action. Structure-activity relationships. The stereochemistry of the molecules.
- Kulcsár Győző Kornél
13.
Transport processes. Transporters and ion channels as drug targets.
- Fülöpné Kiss Edit
14.
Transport processes. Transporters and ion channels as drug targets.
- Fülöpné Kiss Edit
15.
Central and peripheral receptors. Receptors as drug targets.
- Fülöpné Kiss Edit
16.
Central and peripheral receptors. Receptors as drug targets.
- Fülöpné Kiss Edit
17.
Structure and functions of enzymes. Enzymes as drug targets.
- Fülöpné Kiss Edit
18.
Structure and functions of enzymes. Enzymes as drug targets.
- Fülöpné Kiss Edit
19.
Phase 1 metabolic transformations.
- Almási Attila
20.
Phase 1 metabolic transformations.
- Almási Attila
21. Phase 2 metabolic transformations. - Almási Attila
22. Phase 2 metabolic transformations. - Almási Attila
23.
General anesthetics.
- Rozmer Zsuzsanna
24.
General anesthetics.
- Rozmer Zsuzsanna
25.
Narcotic analgesics.
- Kovács-Rozmer Katalin
26.
Narcotic analgesics.
- Kovács-Rozmer Katalin
27.
Nootropic agents and analeptics.
- Kovács-Rozmer Katalin
28.
Nootropic agents and analeptics.
- Kovács-Rozmer Katalin

Practices

1. Laboratory safety and accident protection. The pharmacopoeial nomenclature of substances. Identification and qualitative tests of the European Pharmacopoeia. Limit tests. Acidum hydrochloridum dilutum.
...
2. Laboratory safety and accident protection. The pharmacopoeial nomenclature of substances. Identification and qualitative tests of the European Pharmacopoeia. Limit tests. Acidum hydrochloridum dilutum.
3. Laboratory safety and accident protection. The pharmacopoeial nomenclature of substances. Identification and qualitative tests of the European Pharmacopoeia. Limit tests. Acidum hydrochloridum dilutum.
4. Laboratory safety and accident protection. The pharmacopoeial nomenclature of substances. Identification and qualitative tests of the European Pharmacopoeia. Limit tests. Acidum hydrochloridum dilutum.
5. Calculation of results. Experimental errors. Natrii chloridum, Chloraminum.
6. Calculation of results. Experimental errors. Natrii chloridum, Chloraminum.
7. Calculation of results. Experimental errors. Natrii chloridum, Chloraminum.
8. Calculation of results. Experimental errors. Natrii chloridum, Chloraminum.
9. Inorganic pharmacopoeial substances I. Halogens Natrii bromidum., Kalii bromidum, Ammonii bromidum, Kalii chloridum.
...
10. Inorganic pharmacopoeial substances I. Halogens Natrii bromidum., Kalii bromidum, Ammonii bromidum, Kalii chloridum.
11. Inorganic pharmacopoeial substances I. Halogens Natrii bromidum., Kalii bromidum, Ammonii bromidum, Kalii chloridum.
12. Inorganic pharmacopoeial substances I. Halogens Natrii bromidum., Kalii bromidum, Ammonii bromidum, Kalii chloridum.
13. Inorganic pharmacopoeial substances II. Oxygen group. Aqua purificata, Hydrogenii peroxidum 30 per centum, Natrii hydroxidum.
...
14. Inorganic pharmacopoeial substances II. Oxygen group. Aqua purificata, Hydrogenii peroxidum 30 per centum, Natrii hydroxidum.
15. Inorganic pharmacopoeial substances II. Oxygen group. Aqua purificata, Hydrogenii peroxidum 30 per centum, Natrii hydroxidum.
16. Inorganic pharmacopoeial substances II. Oxygen group. Aqua purificata, Hydrogenii peroxidum 30 per centum, Natrii hydroxidum.
17. Inorganic pharmacopoeial substances III. Sulphur compounds. Natrii thiosulfas, Natrii metabisulfis, Natrii sulfas, Sulphur ad usum externum.
...
18. Inorganic pharmacopoeial substances III. Sulphur compounds. Natrii thiosulfas, Natrii metabisulfis, Natrii sulfas, Sulphur ad usum externum.
19. Inorganic pharmacopoeial substances III. Sulphur compounds. Natrii thiosulfas, Natrii metabisulfis, Natrii sulfas, Sulphur ad usum externum.
20. Inorganic pharmacopoeial substances III. Sulphur compounds. Natrii thiosulfas, Natrii metabisulfis, Natrii sulfas, Sulphur ad usum externum.
21. Inorganic pharmacopoeial substances IV. Nitrogen compounds. Ammonii chloridum, Natrii nitris, Kalii nitras, Bismuthi subnitras.
...
22. Inorganic pharmacopoeial substances IV. Nitrogen compounds. Ammonii chloridum, Natrii nitris, Kalii nitras, Bismuthi subnitras.
23. Inorganic pharmacopoeial substances IV. Nitrogen compounds. Ammonii chloridum, Natrii nitris, Kalii nitras, Bismuthi subnitras.
24. Inorganic pharmacopoeial substances IV. Nitrogen compounds. Ammonii chloridum, Natrii nitris, Kalii nitras, Bismuthi subnitras.
25. 1st Midterm Test. Inorganic pharmacopoeial substances V. Phosphorous compounds. Calcii hydrogenophosphas, Tricalcii phosphas, Natrii dihydrogenophosphas, Dinatrii phosphas.
...
26. 1st Midterm Test. Inorganic pharmacopoeial substances V. Phosphorous compounds. Calcii hydrogenophosphas, Tricalcii phosphas, Natrii dihydrogenophosphas, Dinatrii phosphas.
27. 1st Midterm Test. Inorganic pharmacopoeial substances V. Phosphorous compounds. Calcii hydrogenophosphas, Tricalcii phosphas, Natrii dihydrogenophosphas, Dinatrii phosphas.
28. 1st Midterm Test. Inorganic pharmacopoeial substances V. Phosphorous compounds. Calcii hydrogenophosphas, Tricalcii phosphas, Natrii dihydrogenophosphas, Dinatrii phosphas.
29. Inorganic pharmacopoeial substances VI. Carbon compounds. Carbo activatus, Calcii carbonas, Natrii carbonas, Natrii hydrogencarbonas.
...
30. Inorganic pharmacopoeial substances VI. Carbon compounds. Carbo activatus, Calcii carbonas, Natrii carbonas, Natrii hydrogencarbonas.
31. Inorganic pharmacopoeial substances VI. Carbon compounds. Carbo activatus, Calcii carbonas, Natrii carbonas, Natrii hydrogencarbonas.
32. Inorganic pharmacopoeial substances VI. Carbon compounds. Carbo activatus, Calcii carbonas, Natrii carbonas, Natrii hydrogencarbonas.
33. Inorganic pharmacopoeial substances VII. Pharmaceutical excipients (Seminars).
...
34. Inorganic pharmacopoeial substances VII. Pharmaceutical excipients (Seminars).
35. Inorganic pharmacopoeial substances VII. Pharmaceutical excipients (Seminars).
36. Inorganic pharmacopoeial substances VII. Pharmaceutical excipients (Seminars).
37. Inorganic pharmacopoeial substances VIII. Alkaline earth metals. Earth metals. Silicon compounds. Magnesii sulfas, Magnesii subcarbonas, Magnesii oxydum, Magnesii trisilicas, Silica, colloidal hydrated, Acidum boricum, Borax.
...
38. Inorganic pharmacopoeial substances VIII. Alkaline earth metals. Earth metals. Silicon compounds. Magnesii sulfas, Magnesii subcarbonas, Magnesii oxydum, Magnesii trisilicas, Silica, colloidal hydrated, Acidum boricum, Borax.
39. Inorganic pharmacopoeial substances VIII. Alkaline earth metals. Earth metals. Silicon compounds. Magnesii sulfas, Magnesii subcarbonas, Magnesii oxydum, Magnesii trisilicas, Silica, colloidal hydrated, Acidum boricum, Borax.
40. Inorganic pharmacopoeial substances VIII. Alkaline earth metals. Earth metals. Silicon compounds. Magnesii sulfas, Magnesii subcarbonas, Magnesii oxydum, Magnesii trisilicas, Silica, colloidal hydrated, Acidum boricum, Borax.
41. Inorganic pharmacopoeial substances IX. Metals. Aluminii oxidum hydricum, Aluminii sulfas, Zinci oxydum, Zinci chloridum, Ferrosi sulfas, Kalii permanganas.
...
42. Inorganic pharmacopoeial substances IX. Metals. Aluminii oxidum hydricum, Aluminii sulfas, Zinci oxydum, Zinci chloridum, Ferrosi sulfas, Kalii permanganas.
43. Inorganic pharmacopoeial substances IX. Metals. Aluminii oxidum hydricum, Aluminii sulfas, Zinci oxydum, Zinci chloridum, Ferrosi sulfas, Kalii permanganas.
44. Inorganic pharmacopoeial substances IX. Metals. Aluminii oxidum hydricum, Aluminii sulfas, Zinci oxydum, Zinci chloridum, Ferrosi sulfas, Kalii permanganas.
45. Physico-chemical parameters influencing the biological effect (solubility, pKa, logP). Determination of logP.
...
46. Physico-chemical parameters influencing the biological effect (solubility, pKa, logP). Determination of logP.
47. Physico-chemical parameters influencing the biological effect (solubility, pKa, logP). Determination of logP.
48. Physico-chemical parameters influencing the biological effect (solubility, pKa, logP). Determination of logP.
49. Classification of functional groups and heterocycles (seminar).
...
50. Classification of functional groups and heterocycles (seminar).
51. Classification of functional groups and heterocycles (seminar).
52. Classification of functional groups and heterocycles (seminar).
53. Basics of stereochemistry. Stereochemistry of morphine and derivatives.
...
54. Basics of stereochemistry. Stereochemistry of morphine and derivatives.
55. Basics of stereochemistry. Stereochemistry of morphine and derivatives.
56. Basics of stereochemistry. Stereochemistry of morphine and derivatives.

Seminars

Reading material

Obligatory literature

D. A. Williams, T. L. Lemke (eds.): Foye's Principles of Medicinal Chemistry, 7th edition, Lippincott Williams & Wilkins, Philadelphia, 2013

Literature developed by the Department

Attila Almási, Zsuzsanna Rozmer, Pál Perjési: Pharmaceutical Chemistry I. Laboratory Experiments and Commentary, electronic educational material, PTE 2014

Notes

Pharmaceutical Chemistry Practice I., Laboratory manual, University of Pécs, 2015

Recommended literature

European Pharmacopoeia, EDQM Publication.

Lecture notes.

Conditions for acceptance of the semester

Acknowledgement of the course is in accord with the Code of Studies and Examinations. Participation is both the lectures and the practices is obligatory. Maximum three absences can be accepted both from lectures and practices. There is an obligation to write two midterm tests (week 7. and 12.) from the topics of theory and practice. Students must reach the minimum level of 60% at one test, but the average of the two tests should be above 50 %. Students can have one retake in the end of the semester, if both tests are failed. Students have to write at least four mini-tests on the practices. The average of the results must be at least 50%. The practical work (results of the written tests and the experimental work) is evaluated by a practical grade. Satisfactory (2) evaluation is the minimum requirement of acknowledgement of the semester.

Mid-term exams

If the student did not take part writing the midterm test, she or he can participate the retake, only. There is no chance for extra possibilities.

Making up for missed classes

There is no opportunity to make up missed classes.

Exam topics/questions

Written exam covering the topics of the lectures and the laboratory practices. The result of the written exam must be above 60%. The final grade is based on results of the midterm tests and the written exam. Maximum contribution of the results of the midterm tests to the total score of the written exam is 25%.

Examiners

Almási Attila
Kovács-Rozmer Katalin
Perjési Pál
Rozmer Zsuzsanna

Instructor / tutor of practices and seminars

Almási Attila
Kovács-Rozmer Katalin
Mészáros Petra

Data